Jack Harry Kaye, Executive Chairman of Davion Healthcare Plc, filed a Schedule 13D Amendment No. 2 on November 20, 2026, disclosing four bona fide gifts of ordinary shares made on November 19, 2026, that reduced his beneficial ownership by 1,600,000 shares.
Key Highlights
- Four gifts, no consideration: Kaye transferred a combined 1,600,000 ordinary shares to four individuals on November 19, 2026, with nil consideration for each transfer.
- Ownership reduced: Beneficial ownership fell from 10,268,948 ordinary shares to 8,668,948 ordinary shares following the gifts.
- Post-gift stake: The 8,668,948 shares represent approximately 34.68% of the 25,000,000 ordinary shares outstanding, according to the filing.
- Sole voting and dispositive power: Kaye retains sole voting power and sole dispositive power over all 8,668,948 remaining shares, with no shared voting or dispositive power.
- No retained rights over gifted shares: According to the filing, Kaye "did not retain voting or dispositive power over the gifted shares" and no agreements exist with recipients on voting or disposition.
- Role unchanged: Kaye remains Executive Chairman and a director of the issuer.
Davion Healthcare Executive Chairman Reports Four Outright Share Gifts
Jack Harry Kaye, identified in the filing as Executive Chairman and a director of Davion Healthcare Plc (NASDAQ:DAVI), filed Amendment No. 2 to his Schedule 13D to report transactions that occurred on November 19, 2026. The filing states that four separate bona fide gifts of existing ordinary shares were made to four individuals, with no funds or other consideration received by the reporting person in connection with the transactions.
The four individual transfers, as listed in the filing, consisted of two gifts of 500,000 shares each and two gifts of 300,000 shares each, totaling 1,600,000 ordinary shares. The filing states the transfers "were made without consideration and were not undertaken in connection with any sale, financing, or other capital-raising transaction involving the Issuer." Kaye's beneficial ownership immediately before the gifts stood at 10,268,948 ordinary shares, according to the filing.
Following completion of all four gifts, the filing reports Kaye's beneficial ownership at 8,668,948 ordinary shares, representing approximately 34.68% of the 25,000,000 ordinary shares outstanding as of November 19, 2026. The filing further states that no agreements or understandings exist between Kaye and the recipients concerning voting or disposition of the gifted shares, and that he has not retained voting rights or dispositive authority over those shares. The source of funds code reported is "OO," consistent with the gift characterization. Davion Healthcare Plc is described in the filing as a public limited company incorporated in Ireland, with its principal executive offices located at Unit A, West Cork Business Park, Clonakilty, Co Cork, Ireland.
What Was Disclosed
Kaye's Schedule 13D Amendment No. 2 discloses four bona fide gifts of ordinary shares on November 19, 2026, totaling 1,600,000 shares transferred at nil consideration, reducing his beneficial ownership to 8,668,948 shares, or approximately 34.68% of shares outstanding.



Please wait processing your request...